{"id":6116,"date":"2026-05-13T15:21:40","date_gmt":"2026-05-13T13:21:40","guid":{"rendered":"https:\/\/www.vivebiotech.com\/?post_type=our_science&#038;p=6116"},"modified":"2026-05-15T09:36:43","modified_gmt":"2026-05-15T07:36:43","slug":"cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells","status":"publish","type":"our_science","link":"https:\/\/www.vivebiotech.com\/en\/our_science\/cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells\/","title":{"rendered":"CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","our_science_category":[127],"class_list":["post-6116","our_science","type-our_science","status-publish","hentry","our_science_category-papers-cientificos"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells - VIVEbiotech<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vivebiotech.com\/en\/our_science\/cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells - VIVEbiotech\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vivebiotech.com\/en\/our_science\/cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells\/\" \/>\n<meta property=\"og:site_name\" content=\"VIVEbiotech\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-15T07:36:43+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vivebiotech.com\/en\/our_science\/cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells\/\",\"url\":\"https:\/\/www.vivebiotech.com\/en\/our_science\/cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells\/\",\"name\":\"CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells - VIVEbiotech\",\"isPartOf\":{\"@id\":\"https:\/\/www.vivebiotech.com\/en\/#website\"},\"datePublished\":\"2026-05-13T13:21:40+00:00\",\"dateModified\":\"2026-05-15T07:36:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vivebiotech.com\/en\/our_science\/cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vivebiotech.com\/en\/our_science\/cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vivebiotech.com\/en\/our_science\/cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.vivebiotech.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our Science\",\"item\":\"https:\/\/www.vivebiotech.com\/en\/our-science\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vivebiotech.com\/en\/#website\",\"url\":\"https:\/\/www.vivebiotech.com\/en\/\",\"name\":\"VIVEbiotech\",\"description\":\"VIVEbiotech: Lentiviral vector GMP CDMO\",\"publisher\":{\"@id\":\"https:\/\/www.vivebiotech.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vivebiotech.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.vivebiotech.com\/en\/#organization\",\"name\":\"VIVEbiotech - Your CDMO specialized in lentiviral vectors\",\"alternateName\":\"VIVEbiotech\",\"url\":\"https:\/\/www.vivebiotech.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vivebiotech.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.vivebiotech.com\/wp-content\/uploads\/2025\/03\/logo-vive.jpg\",\"contentUrl\":\"https:\/\/www.vivebiotech.com\/wp-content\/uploads\/2025\/03\/logo-vive.jpg\",\"width\":1973,\"height\":1973,\"caption\":\"VIVEbiotech - Your CDMO specialized in lentiviral vectors\"},\"image\":{\"@id\":\"https:\/\/www.vivebiotech.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/11229973\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells - VIVEbiotech","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vivebiotech.com\/en\/our_science\/cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells\/","og_locale":"en_US","og_type":"article","og_title":"CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells - VIVEbiotech","og_url":"https:\/\/www.vivebiotech.com\/en\/our_science\/cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells\/","og_site_name":"VIVEbiotech","article_modified_time":"2026-05-15T07:36:43+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vivebiotech.com\/en\/our_science\/cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells\/","url":"https:\/\/www.vivebiotech.com\/en\/our_science\/cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells\/","name":"CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells - VIVEbiotech","isPartOf":{"@id":"https:\/\/www.vivebiotech.com\/en\/#website"},"datePublished":"2026-05-13T13:21:40+00:00","dateModified":"2026-05-15T07:36:43+00:00","breadcrumb":{"@id":"https:\/\/www.vivebiotech.com\/en\/our_science\/cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vivebiotech.com\/en\/our_science\/cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.vivebiotech.com\/en\/our_science\/cs1-car-t-targeting-the-distal-domain-of-cs1-slamf7-shows-efficacy-in-high-tumor-burden-myeloma-model-despite-fratricide-of-cd8cs1-expressing-car-t-cells\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.vivebiotech.com\/en\/"},{"@type":"ListItem","position":2,"name":"Our Science","item":"https:\/\/www.vivebiotech.com\/en\/our-science\/"},{"@type":"ListItem","position":3,"name":"CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells"}]},{"@type":"WebSite","@id":"https:\/\/www.vivebiotech.com\/en\/#website","url":"https:\/\/www.vivebiotech.com\/en\/","name":"VIVEbiotech","description":"VIVEbiotech: Lentiviral vector GMP CDMO","publisher":{"@id":"https:\/\/www.vivebiotech.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vivebiotech.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.vivebiotech.com\/en\/#organization","name":"VIVEbiotech - Your CDMO specialized in lentiviral vectors","alternateName":"VIVEbiotech","url":"https:\/\/www.vivebiotech.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vivebiotech.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.vivebiotech.com\/wp-content\/uploads\/2025\/03\/logo-vive.jpg","contentUrl":"https:\/\/www.vivebiotech.com\/wp-content\/uploads\/2025\/03\/logo-vive.jpg","width":1973,"height":1973,"caption":"VIVEbiotech - Your CDMO specialized in lentiviral vectors"},"image":{"@id":"https:\/\/www.vivebiotech.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/11229973\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.vivebiotech.com\/en\/wp-json\/wp\/v2\/our_science\/6116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vivebiotech.com\/en\/wp-json\/wp\/v2\/our_science"}],"about":[{"href":"https:\/\/www.vivebiotech.com\/en\/wp-json\/wp\/v2\/types\/our_science"}],"wp:attachment":[{"href":"https:\/\/www.vivebiotech.com\/en\/wp-json\/wp\/v2\/media?parent=6116"}],"wp:term":[{"taxonomy":"our_science_category","embeddable":true,"href":"https:\/\/www.vivebiotech.com\/en\/wp-json\/wp\/v2\/our_science_category?post=6116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}